The Misuse of Drugs Act 1971 (Temporary Class Drug) Order 2016
S.I. 2016/650 · Made 13 June 2016
Dangerous Drugs
Approved by both Houses of ParliamentMade 13th June 2016
Laid before Parliament- - 15th June 2016
Coming into force 27th June 2016
The Secretary of State makes the following Order in exercise of the powers conferred by sections 2A(1) and (5), 7A(2), (3) and (6) and 31(1) of the Misuse of Drugs Act 1971f1.
None of the substances or products listed in the Schedule to this Order is a Class A drug, a Class B drug or a Class C drug.
The Secretary of State has received a recommendation from the Advisory Council on the Misuse of Drugs under section 2B(1)(b)f2 of the Misuse of Drugs Act 1971 that this Order should be made.
Annotations to the whole text
Footnotes
- f1
-
1971 c. 38. Sections 2A and 7A were inserted by section 151 of, and paragraphs 3 and 8 of Schedule 17 to, the Police Reform and Social Responsibility Act 2011 (c. 13).
- f2
-
Section 2B was inserted by section 151 of, and paragraph 3 of Schedule 17 to, the Police Reform and Social Responsibility Act 2011.
Contents
- 1Citation and commencement
- 2Drugs subject to temporary control
- 3Application of other instruments
- Signature
- Schedule
- 1Paragraph 1
- 2Paragraph 2
- 3Paragraph 3
- 4Paragraph 4
- Explanatory note
1Citation and commencement
This Order may be cited as the Misuse of Drugs Act 1971 (Temporary Class Drug) Order 2016 and comes into force on 27th June 2016.
2Drugs subject to temporary control
The substances and products listed in the Schedule to this Order are specified under section 2A(1) of the Misuse of Drugs Act 1971 as drugs subject to temporary control.
3Application of other instruments
The Misuse of Drugs Regulations 2001f3 apply to the substances and products listed in the Schedule to this Order as if those substances and products were specified in Schedule 1 to those Regulations.
The Misuse of Drugs Regulations (Northern Ireland) 2002f4 apply to the substances and products listed in the Schedule to this Order as if those substances and products were specified in Schedule 1 to those Regulations.
Signature
Karen Bradley
Minister of State
Home Office
13th June 2016
1
The following substances, namely—
-
3,4-Dichloromethylphenidate (3,4-DCMP)
-
4-Methylmethylphenidate
-
Ethylnaphthidate
-
Ethylphenidate
-
Isopropylphenidate (IPP or IPPD)
-
Methylnaphthidate (HDMP-28)
-
Propylphenidate
2
Any stereoisomeric form of a substance specified in paragraph 1.
3
Any salt of a substance specified in paragraph 1 or 2.
4
Any preparation or other product containing a substance specified in any of paragraphs 1 to 3.
Explanatory note
(This note is not part of the Order)
Article 2 of this Order specifies the substances and products listed in the Schedule as drugs subject to temporary control under section 2A(1) of the Misuse of Drugs Act 1971. The substances specified in paragraph 1 of the Schedule are Methylphenidate related materials which are being misused as new psychoactive substances. Paragraphs 2 to 4 of the Schedule specify derivatives of the substances specified in paragraph 1.
These substances and products were made the subject of temporary control by the Misuse of Drugs Act 1971 (Temporary Class Drug) (No. 2) Order 2015. That Order expires on the 26 June 2016 and this Order renews the controls which the 2015 Order had put in place.
Article 3 of this Order provides that the Misuse of Drugs (Safe Custody) Regulations 1973 and the Misuse of Drugs (Safe Custody) (Northern Ireland) Regulations 1973 apply to those substances and products, and the Misuse of Drugs Regulations 2001 and the Misuse of Drugs Regulations (Northern Ireland) 2002 apply to those substances and products as if they were specified in Schedule 1 to each of the relevant Regulations.
In accordance with subsection (6) of section 2A of the Misuse of Drugs Act 1971, the specified substances and products will cease to be subject to temporary control after the expiry of one year or, if earlier, upon the coming into force of an Order in Council under section 2(2) of that Act listing the specified substances and products in Part 1, 2 or 3 of Schedule 2 to that Act.